Literature DB >> 1616355

Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue.

P Kahle1, J G Saal, K Schaudt, J Zacher, P Fritz, G Pawelec.   

Abstract

In a study aimed at correlating cytokine levels in synovial fluid with the pathology of rheumatoid arthritis (RA), tumour necrosis factor alpha, interleukin 1 beta and interferon gamma were immunoassayed in 27 patients with RA, 16 patients with other arthritides, 23 with osteoarthritis, 13 patients with trauma, and 18 patients at necropsy without inflammatory disease and not known to have had joint disease (median 27 hours after death). The results for interleukin 1 beta clearly show higher cytokine levels in patients with RA and other arthritides than in patients with osteoarthritis, trauma, or the patients at necropsy. Interferon gamma levels in patients with osteoarthritis and the patients at necropsy, however, were significantly greater than in patients with RA, and tumour necrosis factor alpha levels were also greater in the patients at necropsy compared with patients with RA. This study also correlated histomorphological patterns of synovitis and indicators of local inflammatory activity with synovial fluid cytokine levels, showing, for example, a positive association of interleukin 1 beta titre and a negative association of interferon gamma titre with ulcerogranulomatous synovitis (itself associated with RA). Taken together, these results extend and strengthen data suggesting a possible part played by increased synovial fluid levels of interleukin 1 beta in joint destruction in RA, but provide no evidence for increases in levels of tumour necrosis factor alpha or interferon gamma affecting the disease pathology.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1616355      PMCID: PMC1004735          DOI: 10.1136/ard.51.6.731

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

1.  The immunohistology of synovial lining cells in normal and inflamed synovium.

Authors:  N A Athanasou; J Quinn; A Heryet; B Puddle; C G Woods; J O McGee
Journal:  J Pathol       Date:  1988-06       Impact factor: 7.996

2.  Characteristics of tumor necrosis factor production in rheumatoid arthritis.

Authors:  D E Yocum; L Esparza; S Dubry; J B Benjamin; R Volz; P Scuderi
Journal:  Cell Immunol       Date:  1989-08       Impact factor: 4.868

3.  Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.

Authors:  F M Brennan; C O Zachariae; D Chantry; C G Larsen; M Turner; R N Maini; K Matsushima; M Feldmann
Journal:  Eur J Immunol       Date:  1990-09       Impact factor: 5.532

Review 4.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1990-03

5.  Synovial fluid concentration of five different cytokines in rheumatic diseases.

Authors:  C I Westacott; J T Whicher; I C Barnes; D Thompson; A J Swan; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

6.  Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.

Authors:  T Saxne; M A Palladino; D Heinegård; N Talal; F A Wollheim
Journal:  Arthritis Rheum       Date:  1988-08

7.  Multiple cytokine activities and loss of interleukin 2 inhibitor in synovial fluids of patients with rheumatoid arthritis.

Authors:  N Yamagata; K Kobayashi; T Kasama; T Fukushima; M Tabata; I Yoneya; Y Shikama; S Kaga; M Hashimoto; K Yoshida
Journal:  J Rheumatol       Date:  1988-11       Impact factor: 4.666

8.  Production of tumour necrosis factor-alpha, interferon-gamma and interleukin-2 by peripheral blood mononuclear cells of subjects suffering from rheumatoid arthritis.

Authors:  P Franchimont; A Reuter; Y Vrindts-Gevaert; M Bastings; M Malaise; C Sondag; M C Frere; P Gysen
Journal:  Scand J Rheumatol       Date:  1988       Impact factor: 3.641

9.  Lymphokine production in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  R M McKenna; J A Wilkins; R J Warrington
Journal:  J Rheumatol       Date:  1988-11       Impact factor: 4.666

10.  Impaired mitogen-induced interferon-gamma production in rheumatoid arthritis and related diseases.

Authors:  T Stolzenburg; H Binz; A Fontana; M Felder; F J Wagenhaeuser
Journal:  Scand J Immunol       Date:  1988-01       Impact factor: 3.487

View more
  51 in total

1.  Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression.

Authors:  J A Quayle; F Watson; R C Bucknall; S W Edwards
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Th-17 associated cytokines in patients with reactive arthritis/undifferentiated spondyloarthropathy.

Authors:  Amit Kumar Singh; Ramnath Misra; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2010-12-22       Impact factor: 2.980

3.  Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes.

Authors:  A W M Cheng; T V Stabler; M Bolognesi; V B Kraus
Journal:  Osteoarthritis Cartilage       Date:  2010-10-28       Impact factor: 6.576

4.  Protective effects of indomethacin and cyclophosphamide but not of infliximab on liver metabolic changes caused by adjuvant-induced arthritis.

Authors:  Maria Angélica Raffaini Covas Pereira da Silva; Ciomar Aparecida Bersani-Amado; Emy Luiza Ishii-Iwamoto; Lívia Bracht; Silvana Martins Caparroz-Assef
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

Review 5.  Arthroscopic synovectomy in rheumatoid arthritis of wrist.

Authors:  Sung-Jae Kim; Kwang-Am Jung
Journal:  Clin Med Res       Date:  2007-12-17

6.  Inhibition of matrix metalloproteinases enhances in vitro repair of the meniscus.

Authors:  Amy L McNulty; J Brice Weinberg; Farshid Guilak
Journal:  Clin Orthop Relat Res       Date:  2008-10-31       Impact factor: 4.176

Review 7.  The roles of catabolic factors in the development of osteoarthritis.

Authors:  Dominick J Blasioli; David L Kaplan
Journal:  Tissue Eng Part B Rev       Date:  2013-12-11       Impact factor: 6.389

8.  Beneficial effects of cerium oxide nanoparticles in development of chondrocyte-seeded hydrogel constructs and cellular response to interleukin insults.

Authors:  Sathish Ponnurangam; Grace D O'Connell; Irina V Chernyshova; Katherine Wood; Clark Tung-Hui Hung; Ponisseril Somasundaran
Journal:  Tissue Eng Part A       Date:  2014-06-25       Impact factor: 3.845

9.  Evaluation of synovial cytokine patterns in rheumatoid arthritis and osteoarthritis by quantitative reverse transcription polymerase chain reaction.

Authors:  S Wagner; P Fritz; H Einsele; S Sell; J G Saal
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

10.  Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts.

Authors:  F Bellucci; P Cucchi; C Catalani; S Giuliani; S Meini; C A Maggi
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.